0001214659-22-004372.txt : 20220325 0001214659-22-004372.hdr.sgml : 20220325 20220325175038 ACCESSION NUMBER: 0001214659-22-004372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220323 FILED AS OF DATE: 20220325 DATE AS OF CHANGE: 20220325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Belldegrun Arie CENTRAL INDEX KEY: 0001296549 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 22772694 MAIL ADDRESS: STREET 1: UCLA SCHOOL OF MEDICINE STREET 2: 10833 LE CONTE 66-118 CHS BOX 951738 CITY: LOS ANGELES STATE: CA ZIP: 9095-1738 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-55853.xml PRIMARY DOCUMENT X0306 4 2022-03-23 0001737287 Allogene Therapeutics, Inc. ALLO 0001296549 Belldegrun Arie 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false Stock Option (Right to Buy) 9.69 2022-03-23 4 A false 1458333 0.00 A 2032-03-23 Common Stock 1458333 1458333 D 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. /s/ Veer Bhavnagri, Attorney-in-Fact for Arie Belldegrun 2022-03-23